Frey EN , Pavlovicz RE , Wegman CJ , Li C , Askwith CC .

R01 NS062967 NINDS NIH HHS , P30 NS045758 NINDS NIH HHS , T32 GM068412 NIGMS NIH HHS

	Figure 3. MTSET modification of desensitized L280C and L415C.A. Representative traces of calcium-dependent gating of unmodified L280C and L415C. Oocytes were exposed to the indicated pH (pH 6.8 for L280C or pH 6.9 for L415C) in either 5.0 mM Ca2+ or nominal Ca2+ -free solutions to foster ASIC1a transition to distinct gating states at the same pH. B. Quantification of calcium-dependent gating. The presence of 5.0 mM Ca2+ maintained L280C and L415C in the closed state when cells were treated with the conditioning pH (pH 6.8 for L280C or pH 6.9 for L415C) for ~2 minutes. This was evident by robust pH 5.0 evoked currents following conditioning with the mildly acidic pH (n = 6-8). Conditioning with the same pH in nominal Ca2+ induced steady-state desensitization of L280C and L415C (n = 6-8). C. Schematic of the experiment to assess accessibility. The closed state of ASIC1a was maintained by conditioning with pH 6.8 (L280) or 6.9 (L415) containing 5 mM Ca2+. The desensitized state was evoked by conditioning with the same pH in nominal calcium. 300 µM MTSET was applied in the conditioning pH for the indicated time and then excess MTSET was washed away with conditioning solution. Oocytes were then returned to pH 7.4 before activation with pH 5.0. D. Representative traces of L280C pH 5.0-evoked currents before (control) and after 6 minutes of MTSET incubation. E. Quantification of residual current of L280C after MTSET exposure for the indicated time (n = 4-6). F. Representative traces of L415C before (control) and after 60 second intervals of MTSET incubation. G. Quantification of residual current of L415C after MTSET exposure for the indicated time (n = 4-6). Curves represent one-phase association exponential fits of the data points. Data are mean ± SEM. “***” indicates p < 0.001 compared to 5.0 mM Ca2+ conditioning.
	Figure 2. MTSET modification of L280C, I307C, and L415C.A. Effect of MTSET on wildtype or mutant ASIC1a expressed in Xenopus oocytes. MTSET (300 µM) was applied at pH 7.4 for 3 minutes and removed by washing with pH 7.4 solutions. pH 5.0-evoked currents after MTSET incubation (“+ MTSET”) were compared to control currents in the same oocyte measured before MTSET application (“Control”). B–C. Quantification of (B) tau of inactivation (n = 6-8) and (C) residual current (n = 6-7). D. Representative recordings of steady-state desensitization (SSD) before and after MTSET modification. Oocytes were maintained at a basal of pH 7.9 and then incubated with pH 6.7 for 2 minutes to induce SSD (shaded bars) prior to activation with pH 5.0 (white bars). E. Quantification of MTSET-dependent changes in SSD (n = 5-6). F. Representative traces of MTSET exposure on pH-dependent activation. MTSET was applied as above and the response to pH 5.0 (white bars) or pH 6.5 (gray bars) from basal pH 7.4 was measured. G. Quantification of pH 6.5-mediated activation before and after MTSET modification (n = 6-8). Data are mean ± SEM. “**” and “***” indicate p-values < 0.01 and 0.001, respectively. Significance was determined with paired Student’s t-tests.
	Figure 4. FRRFa modulation of L280C.A. FRRFa increases residual current of wildtype and L280C. FRRFa (100 µM) was applied for 1 minute at pH 7.4 prior to activation with pH 5.0. For L280C, arrowheads highlight the FRRFa-induced increase in peak current amplitude. B. Quantification of residual current (n = 14-17). C. Quantification of FRRFa modulation on pH 5.0-evoked peak current amplitude. The percent change in amplitude was determined by subtracting the pH 5.0-evoked peak current amplitude of vehicle from the pH 5.0 evoked peak current amplitude evoked after FRRFamide modulation and normalizing to the vehicle peak current amplitude from the same cell (n = 17-25). D. Representative trace of FRRFa modulation on steady-state desensitization. 100 µM FRRFa or vehicle was applied for 1 minute at basal pH 7.4 and again during the 2 minute incubation with conditioning pH 6.7. Proton-gated current was evoked with pH 5.0 (white bar). E. Quantification of FRRFa modulation of steady-state desensitization (n = 4). F–G. FRRFamide concentration response curve for wildtype ASIC1a (F) and L280C (G). The effect of FRRFamide on residual current was assessed. Our data suggest that 100 µM FRRFa induced a maximal response on wildtype ASIC1a as 300 µM FRRFa was not significantly different from 100 µM FRRFa (n = 5, p = 0.69 paired Student’s t-test, difference between 100µM and 300µM was 10.42% ± 11.25%; data not shown). Based on this information, the calculated EC50 for wildtype ASIC1a was 20 ± 4 µM and 14 ± 4 µM for L280C (n = 6-8, p = 0.34). Data are mean ± SEM. “**” and “***” indicates p-value < 0.01 and 0.001 respectively.
	Figure 5. FRRFa impairs MTSET modification.A. Schematic of MTSET/peptide experimental design. 100 µM peptide or vehicle was applied for 1 minute before application of MTSET (in the presence of vehicle or peptide). Excess MTSET was removed by washing in peptide (or vehicle) containing solutions. Finally, peptide (or vehicle) was washed-out thoroughly and residual current was measured. B. Representative traces of L280C pH 5.0-evoked currents following 2.5 minutes of MTSET modification in the presence of vehicle, FRRFa, or FRRF (no amide). C. Quantification of residual current after exposure to MTSET in the presence of vehicle, 100 µM FRRFa, or 100 µM FRRF (no amide). Curves represent one-phase association exponential fits of the data points. FRRFa significantly altered MTSET modification (p < 0.001, 2-way ANOVA). No difference was observed between Vehicle and FRRF (no amide). Data are mean ± SEM, n = 3-22.
	Figure 6. FRRFa modulates L280C after MTSET modification.A. Schematic of experimental design and representative traces. Left Panel: L280C was activated with pH 5.0 with and without 100 µM FRRFa. Right Panel: L280C was modified with 300 µM MTSET for 3 minutes at pH 7.4. After treatment, MTSET was removed by washing with pH 7.4 and pH 5.0-evoked current was recorded in the absence of FRRFamide. Channels were then washed with pH 7.4 and allowed to recover for 1 minute. Then pH 7.4 solutions containing 100 µM FRRFa were applied for 1 minute. After application of FRRFa, channels were activated with pH 5.0. For quantification (B–D), % change was determined by subtracting the stated characteristic (peak amplitude, residual current, or τinact) with FRRFa from control (no peptide) and normalized to the no peptide response. B. Quantification of % change in peak current amplitude. The magnitude of the change in peak current amplitude evoked with FRRFa was independent of MTSET modification (n = 8-11, p = 0.6). C. Quantification of the % change in the rate of inactivation (τinact). FRRFa response on inactivation after MTSET was not significantly different from FRRFa response on unmodified L280C (n = 8-11, p = 0.9). D. Quantification of % change in residual current. After MTSET modification, FRRFa still increased residual current (n = 8, p = 0.02, paired Student’s t-test), but this was not as robust as FRRFa-induced residual current of unmodified L280C (n = 8-11, p = 0.03). Data are mean ± SEM. “*” indicates p < 0.05 and n.s. indicates no significant difference.
	Figure 1. Location and characteristics of L280C, I307C, and L415C in human ASIC1a. A–B. Human ASIC1a was modeled based on the chicken ASIC1 crystal structure (PDB ID: 3HGC). One subunit has been removed to show the inside of the central vestibule. The subunits are color-coded to highlight different regions of the ASIC1a structure. The boxed region is magnified in B to illustrate the positions of L280, I307, and L415. Images were rendered using the UCSF Chimera package [63,64]. C. Representative recordings of acid-activated currents in Xenopus oocytes expressing wild-type human ASIC1a, L280C, I307C, or L415C. Basal pH was maintained at pH 7.4 before application of pH 5.0 (white bars above trace). D. Quantification of the tau of inactivation (n = 10-14), calculated through a single exponential fit of the decay phase of the acid-evoked current. E. Quantification of proton-dependent activation (n = 6-9). I/Imax is the peak current amplitude evoked from test pH conditions normalized to peak current amplitude evoked with pH 5.0. F. Quantification of the proton-dependence of steady-state desensitization (n = 6-10). I/Imax. is the peak current amplitude of pH 5.0-evoked currents after conditioning in the test pH normalized to the pH 5.0-evoked current after conditioning in pH 7.9 (see methods). Data are mean ± SEM. “***” indicates a p-value < 0.001, respectively. “n.s.” indicates no significant difference.

Alijevic, Subtype-specific modulation of acid-sensing ion channel (ASIC) function by 2-guanidine-4-methylquinazoline. 2012, Pubmed, Xenbase

Alijevic, Subtype-specific modulation of acid-sensing ion channel (ASIC) function by 2-guanidine-4-methylquinazoline. 2012, Pubmed , Xenbase
Allen, Modulation of ASIC channels in rat cerebellar Purkinje neurons by ischaemia-related signals. 2002, Pubmed
Alvarez de la Rosa, Structure and regulation of amiloride-sensitive sodium channels. 2000, Pubmed
Askwith, Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. 2000, Pubmed , Xenbase
Askwith, DEG/ENaC ion channels involved in sensory transduction are modulated by cold temperature. 2001, Pubmed , Xenbase
Babini, Alternative splicing and interaction with di- and polyvalent cations control the dynamic range of acid-sensing ion channel 1 (ASIC1). 2002, Pubmed , Xenbase
Baconguis, Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes. 2012, Pubmed
Bargeton, The contact region between three domains of the extracellular loop of ASIC1a is critical for channel function. 2010, Pubmed , Xenbase
Behan, Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration. 2013, Pubmed
Bohlen, A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain. 2011, Pubmed , Xenbase
Catarsi, Selective modulation of heteromeric ASIC proton-gated channels by neuropeptide FF. 2001, Pubmed , Xenbase
Chen, The tarantula toxin psalmotoxin 1 inhibits acid-sensing ion channel (ASIC) 1a by increasing its apparent H+ affinity. 2005, Pubmed , Xenbase
Chen, Strong modulation by RFamide neuropeptides of the ASIC1b/3 heteromer in competition with extracellular calcium. 2006, Pubmed , Xenbase
Coric, The extracellular domain determines the kinetics of desensitization in acid-sensitive ion channel 1. 2003, Pubmed , Xenbase
Coryell, Targeting ASIC1a reduces innate fear and alters neuronal activity in the fear circuit. 2007, Pubmed
Coryell, Restoring Acid-sensing ion channel-1a in the amygdala of knock-out mice rescues fear memory but not unconditioned fear responses. 2008, Pubmed
Coryell, Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior. 2009, Pubmed
Cushman, A conformation change in the extracellular domain that accompanies desensitization of acid-sensing ion channel (ASIC) 3. 2007, Pubmed
Dawson, Structure of the acid-sensing ion channel 1 in complex with the gating modifier Psalmotoxin 1. 2012, Pubmed
Della Vecchia, Gating transitions in the palm domain of ASIC1a. 2013, Pubmed , Xenbase
Deval, Effects of neuropeptide SF and related peptides on acid sensing ion channel 3 and sensory neuron excitability. 2003, Pubmed
Diochot, Black mamba venom peptides target acid-sensing ion channels to abolish pain. 2012, Pubmed , Xenbase
Diochot, A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons. 2004, Pubmed , Xenbase
Dubé, Acid sensing ion channels and acid nociception. 2009, Pubmed
Escoubas, Isolation of a tarantula toxin specific for a class of proton-gated Na+ channels. 2000, Pubmed , Xenbase
Fiser, Modeling of loops in protein structures. 2000, Pubmed
Friese, Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. 2007, Pubmed
Gonzales, Pore architecture and ion sites in acid-sensing ion channels and P2X receptors. 2009, Pubmed
Gründer, Toxin binding reveals two open state structures for one acid-sensing ion channel. 2012, Pubmed
Hoagland, Identification of a calcium permeable human acid-sensing ion channel 1 transcript variant. 2010, Pubmed , Xenbase
Immke, Protons open acid-sensing ion channels by catalyzing relief of Ca2+ blockade. 2003, Pubmed
Jasti, Structure of acid-sensing ion channel 1 at 1.9 A resolution and low pH. 2007, Pubmed
Knap, Chemical modification of the RTEM-1 thiol beta-lactamase by thiol-selective reagents: evidence for activation of the primary nucleophile of the beta-lactamase active site by adjacent functional groups. 1989, Pubmed
Li, Leu85 in the beta1-beta2 linker of ASIC1 slows activation and decreases the apparent proton affinity by stabilizing a closed conformation. 2010, Pubmed , Xenbase
Li, Asn415 in the beta11-beta12 linker decreases proton-dependent desensitization of ASIC1. 2010, Pubmed , Xenbase
Lingueglia, FMRFamide-gated sodium channel and ASIC channels: a new class of ionotropic receptors for FMRFamide and related peptides. 2006, Pubmed
Mazzuca, A tarantula peptide against pain via ASIC1a channels and opioid mechanisms. 2007, Pubmed
Nishimura, Role of FMRFamide-activated brain sodium channel in salt-sensitive hypertension. 2000, Pubmed
Ostrovskaya, Modulatory action of RFamide-related peptides on acid-sensing ionic channels is pH dependent: the role of arginine. 2004, Pubmed
Pettersen, UCSF Chimera--a visualization system for exploratory research and analysis. 2004, Pubmed
Pignataro, Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia. 2007, Pubmed
Roberts, Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. 1986, Pubmed
Sali, Comparative protein modelling by satisfaction of spatial restraints. 1993, Pubmed
Shen, Statistical potential for assessment and prediction of protein structures. 2006, Pubmed
Sherwood, Endogenous arginine-phenylalanine-amide-related peptides alter steady-state desensitization of ASIC1a. 2008, Pubmed , Xenbase
Sherwood, Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death. 2009, Pubmed , Xenbase
Springauf, The interaction between two extracellular linker regions controls sustained opening of acid-sensing ion channel 1. 2011, Pubmed , Xenbase
Staniland, Mice lacking acid-sensing ion channels (ASIC) 1 or 2, but not ASIC3, show increased pain behaviour in the formalin test. 2009, Pubmed
Vergo, Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. 2011, Pubmed
Vralsted, Expressing acid-sensing ion channel 3 in the brain alters acid-evoked currents and impairs fear conditioning. 2011, Pubmed
Waldmann, A proton-gated cation channel involved in acid-sensing. 1997, Pubmed , Xenbase
Wemmie, Acid-sensing ion channels in pain and disease. 2013, Pubmed
Wemmie, Acid-sensing ion channel 1 is localized in brain regions with high synaptic density and contributes to fear conditioning. 2003, Pubmed
Wemmie, Overexpression of acid-sensing ion channel 1a in transgenic mice increases acquired fear-related behavior. 2004, Pubmed
Wemmie, Acid-sensing ion channels: advances, questions and therapeutic opportunities. 2006, Pubmed
Xie, DRASIC contributes to pH-gated currents in large dorsal root ganglion sensory neurons by forming heteromultimeric channels. 2002, Pubmed
Xie, ASIC3 and ASIC1 mediate FMRFamide-related peptide enhancement of H+-gated currents in cultured dorsal root ganglion neurons. 2003, Pubmed
Xiong, Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. 2004, Pubmed
Yang, UCSF Chimera, MODELLER, and IMP: an integrated modeling system. 2012, Pubmed
Yu, A nonproton ligand sensor in the acid-sensing ion channel. 2010, Pubmed
Yu, Atomic level characterization of the nonproton ligand-sensing domain of ASIC3 channels. 2011, Pubmed
Zhang, Gating of acid-sensitive ion channel-1: release of Ca2+ block vs. allosteric mechanism. 2006, Pubmed , Xenbase
Ziemann, Seizure termination by acidosis depends on ASIC1a. 2008, Pubmed